
Anpharm Przedsiębiorstwo Farmaceutyczne S.A.
Manufacture of pharmaceutical preparations
Overview
Anpharm Przedsiębiorstwo Farmaceutyczne is a manufacturing facility of the Servier Group in Poland that produces pharmaceuticals. It adheres to GMP quality standards and exports its products to 30 countries, focusing on therapeutic areas such as cardiometabolism, oncology, and neurology.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 33 days early. All were audited by a statutory auditor.
- 202525/02/2026
- 202414/04/2025
- 202310/04/2024
- 202213/04/2023
- 202113/04/2022
- 202026/02/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
- anpharm.plStrona główna – Servier Anpharm PolskaWordPress 6.7Yoast SEOApache
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 11 marks have expired or were not registered. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| glimebet (word) | – | |
| ANPHARM | – | |
| CORAMIL (word) | – | |
| RAMIVAC (word) | – | |
| URIBICALAN (word) | – |
Job offers
The company has its own careers page: anpharm.pl/dolacz-do-nas.
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 1995-12-01.
- 35 1840 0007 2211 2410 0819 2510
- 89 1840 0007 2211 2410 0810 1619
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Biofarm sp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Delpharm Poznań S.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne Polfa S.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o. | $102,266,019.67 | lekam.pl | ||
| Natur Produkt Pharma sp. z o.o. | $93,854,070.54 | nppharma.pl | ||
| Sandoz Polska sp. z o.o. | $89,136,265.74 | sandoz.com | ||
| ICN Polfa Rzeszów S.A. | $85,044,250.03 | icnpolfa.pl | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Wörwag Pharma Operations sp. z o.o. | $46,828,794.87 | woerwagpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2008-04-14 | Share capital reduction (10,418,998.00 PLN → 7,892,148.00 PLN) | |
| 2002-03-18 | Share capital increase (7,561,998.00 PLN → 10,418,998.00 PLN) | |
| 2001-07-09 | Entered in the register |
FAQ
Last updated: 2026-04-01